1 documents found
Information × Registration Number 0310U002014, 0108U000193 , R & D reports Title To determine molecular changes in cancer cells of the patients with refractory forms of malignant lymphomas, to define diagnostic and prognostic value of these changes, to develop the methods of treatment depend on levels of these changes. popup.stage_title Розробити оптимальні методи лікування хворих на рефрактерні злоякісні лімфоми з урахуванням рівня експресії РКС Head Kryachok Iryna, Registration Date 21-01-2010 Organization Nacional Cancer Institute popup.description2 Object of study - patients with refractory forms of malignant lymphomas. Objective of study - to determine the diagnostic and prognostic value of the molecular changes in cancer cells of patients with refractory forms of malignant lymphomas and to develop the methods of treatment depending on levels of these changes. Methods of study - clinical, hematological, morphological, imunohistochemical, radiological, statistical. To asses not only clinical, but also immunohistochemical prognostic markers of the disease while primary diagnoses and to assign the group of primary refractive patients. This group need more aggressive scheme of polychemiotherapy in the first line of treatment to achieve a complete response. Field of use - oncology. Product Description popup.authors Алексик Олена Михайлівна Губарева Ганна Олександрівна Мартинчик Аріна Валеріївна popup.nrat_date 2020-04-02 Close
R & D report
Head: Kryachok Iryna. To determine molecular changes in cancer cells of the patients with refractory forms of malignant lymphomas, to define diagnostic and prognostic value of these changes, to develop the methods of treatment depend on levels of these changes.. (popup.stage: Розробити оптимальні методи лікування хворих на рефрактерні злоякісні лімфоми з урахуванням рівня експресії РКС). Nacional Cancer Institute. № 0310U002014
1 documents found

Updated: 2026-03-21